Ortho RTI Partners With Amp Recover for Upcoming Clinical Trial

AMP Recover announced this week a new partnership with Ortho Regenerative Technologies Inc. (Ortho RTI, CSE: ORTH, OTCQB: ORTIF) for an upcoming clinical trial. Ortho RTI’s team of clinical researchers will use AMP Recover’s orthopedic management platform to deliver rehabilitation protocols to patients and monitor their progress throughout the study.  “We are excited to be … Read more

Royal Biologics Wound Care Portfolio Receives High-Tier Reimbursement

Royal Biologics, an Autologous and Live Cellular solutions-focused company, announced today that beginning Jan. 1, 2021, Cryo-Cord™ Placental Allograft, Amnio-Maxx™ Placental Allograft, Amnio-Maxx™ Lite Placental Allograft and Derm-Maxx™ Dermal Allograft will be placed in the high-tier reimbursement category for skin substitutes under the Center for Medicare and Medicaid (CMS) Hospital Outpatient Prospective Payment System. With this new payment designation, hospital outpatient … Read more